114012-12-3 Hazards Identification
Pictogram(s):

Signal:
Warning
GHS Hazard Statements:
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
Precautionary Statement Codes:
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501
Hazard Classes and Categories:
Skin Irrit. 2 (100%)
Eye Irrit. 2 (100%)
STOT SE 3 (100%)
114012-12-3 Usage
Uses
Used in Pharmaceutical Industry:
PHACLOFEN is used as a GABAB receptor antagonist for its potential therapeutic applications in treating various conditions related to the central nervous system. Its ability to selectively target GABAB receptors makes it a valuable tool in research and drug development for conditions such as muscle spasms, spasticity, and certain neurological disorders.
Used in Research Applications:
In the field of scientific research, PHACLOFEN is used as a research tool to study the role of GABAB receptors in cellular and molecular processes. Its selective antagonism of GABAB receptors allows researchers to investigate the specific functions and signaling pathways associated with these receptors, contributing to a better understanding of their role in health and disease.
Used in Drug Development:
PHACLOFEN is also used in the development of new drugs targeting GABAB receptors. Its selective antagonistic properties make it a promising candidate for the development of novel therapeutics for conditions where modulation of GABAB receptor activity may be beneficial. This includes potential applications in the treatment of neurological disorders, pain management, and other related conditions.
Biological Activity
Selective GABA B antagonist. Phosphono analog of GABA B agonist baclofen ((RS)-4-Amino-3-(4-chlorophenyl)butanoic acid ).
Biochem/physiol Actions
Phaclofen plays a vital role in identifying the physiological importance of central and peripheral bicuculline-insensitive receptors with which GABA and (?) baclofen interact. Phaclofen acts as a GABAB receptor antagonist. Phaclofen has an ability to reversibly block the late, bicuculline resistant, K+ dependent inhibitory postsynaptic potential (IPSP) logged in projection cells of the cat and rat dorsal lateral geniculate nucleus and in rat hippocampal CA1 pyramidal neurons.
Check Digit Verification of cas no
The CAS Registry Mumber 114012-12-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,4,0,1 and 2 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 114012-12:
(8*1)+(7*1)+(6*4)+(5*0)+(4*1)+(3*2)+(2*1)+(1*2)=53
53 % 10 = 3
So 114012-12-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H13ClNO3P/c10-9-3-1-7(2-4-9)8(5-11)6-15(12,13)14/h1-4,8H,5-6,11H2,(H2,12,13,14)
114012-12-3Relevant academic research and scientific papers
The Synthesis of Phosphonobaclofen, an Antagonist of Baclofen
Chiefari, John,Galanopoulos, Speros,Janowski, Wit K.,Kerr, David I. B.,Prager, Rolf H.
, p. 1511 - 1518 (2007/10/02)
Phosphonobaclofen 3-amino-2-(4-chlorophenyl)propylphosphonic acid, has been synthesized in five steps from ethyl 3-(4-chlorophenyl)but-2-enoate, and is a specific antagonist of baclofen.The alternative synthetic pathways, involving conjugate addition of phosphite to 2-(4-chlorophenyl)propenenitrile and of cyanide to 2-(4-chlorophenyl)ethylphosphonate ester, failed.Cyanide ion did add efficiently to ethyl 3-(4-chlorophenyl)-2-diethoxyphosphinylprop-2-enoate and hydrogenation followed by hydrolysis of the product gave (2 S, 3 S)- and (2R, 3 R)-4-amino-3-(4-chlorophenyl)-2-phosphonobutanoic acid, which is also undergoing pharmacological evaluation.